Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates header labels (Intervention/Treatment) while removing the older label (Intervention / Treatment) and the older revision note (Revision: v3.5.5), and introduces a new revision version (Revision: v3.6.0). Additionally, recruitment status is updated with 'No longer looking for participants', indicating that enrollment is closed.SummaryDifference0.4%

- Check10 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor version update. No substantive study content or functionality changes are indicated by the provided data or screenshots.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new site revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, indicating a small software update to the page rendering.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical study record details.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the revision history.SummaryDifference0.0%

- Check67 days agoChange DetectedLocation name updated from Padua to Padova for the Veneto, Italy site (35128).SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.